Microfluidic Applications in the Pharmaceutical, Life Sciences, In-Vitro Diagnostic and Medical Device Markets Report 2013
- ID: 2633004
- June 2013
- Region: Global
- 271 Pages +
- Yole Développement
How life science and in vitro diagnostics applications are driving an impressive 27% growth for the microfluidic device market.
The microfluidic device market is expected to reach $5.7B by 2018!
The microfluidic device market will grow swiftly, from $1.4B in 2013 to $5.7B by 2018. This impressive 27% growth will be fueled mainly by Pharmaceutical research and Point-of-Care applications.
Facing new challenges, the healthcare industry is currently moving toward personalized medicine. In this context, the line between traditional markets (pharmaceutical and in vitro diagnostic markets) has blurred. More than ever, rapid, accurate tests are needed to increase pharmaceutical research yield and better monitor/cure patients.
By offering innovative solutions, microfluidic technologies have successfully managed to fill the gap. This new Yole Développement report provides a complete analysis of microfluidic device markets and technologies. Based on an accurate investigation of the last three years’ events, this report consolidates market data from 2010-2012 and provides forecasts for 2013-2018.
Microfluidic devices can be produced either by pure microfluidics fabs or in-house by fully integrated players. After revealing the top 15 pure microfluidic fab players, the report looks at the “hidden” market linked to in-house production.
These microfluidic devices can either be used directly for some applications (analytical devices, flow chemistry, etc.) or must be completed by reagents/biological content. The distinction between the microfluidic device market (first-level package device) and the microfluidic technologybased test market has also been calculated.
Discover the microfluidic market’s complex organization, broken down in nine segments
Today, microfluidic devices are widely accepted in several applications. Nevertheless, the advantages and motivations for adopting microfluidic technologies are highly-dependent on the targeted application. For example, the added value of microfluidic devices in Point-of-Care applications depends on the associated small volume of necessary reagents, low-cost disposables and high sensibility. Contrarily, the advantages for pharmaceutical research applications are to allow process automation and multiplexed assays.
This report provides a market segmentation covering the following applications:
- General dispensing
- Drug delivery
- Accurate dispensing
- Analytical devices
- Clinical and veterinary diagnostics
- Point-of-care testing
- Industrial and environmental testing
- Pharmaceutical and life science
- Microreaction technology
Each application is presented with market data, trends/drivers, key players and technologies used.
Recent changes in the material mix provide new opportunities for polymer and silicon
Different materials are used to manufacture microfluidic devices: glass, polymer, silicon, metal and ceramics. Whereas polymer is becoming the reference substrate for Point-Of-Care applications, glass is still the main substrate for analytical devices.
The penetration rate of each substrate vs. Microfluidic application is presented in this report.
Recently, the material mix has changed due to:
- The need to reduce device cost for some applications (i.e. switching from glass to polymer)
- The need to add new on-chip functions linked to emerging applications (i.e. growth of silicon use)
Material mix changes present exciting opportunities for new players entering the microfluidic market. For example, the high growth rate of next-generation sequencing technologies is opening new doors for silicon players.
This report provides an analysis of these new opportunities, in line with material mix changes.
Objectives of the report
- To provide a complete analysis of microfluidic devices, applications, markets and technologies. Thanks to an exclusive market segmentation, both market trends and main players are presented for each product category.
- To cover the microfluidics device and final diagnostic test markets for a better understanding of how value is spread across the supply chain.
- To present new, promising applications for microfluidics technologies.
What ’s new compared to last ANALYSIS
- Based on sales data from the microfluidic device market’s top 150 players, the entire microfluidic landscape has been recalculated for this report
- We’ve gone a step further by refining our forecasts: microfluidic device market vs. final diagnostic test market
- Analysis of the material mix evolution (polymer, glass, silicon, metal and ceramics) for microfluidic applications
- A new section called “emerging applications” discusses longterm opportunities for microfluidic technologies
- Value chain and supply chain analyses have been updated and better developed
Key features of the report
- Market evolution and key events analysis for the last three years, including mergers & acquisitions, innovative product launches and collaborations
- 2012-2018 microfluidic device forecast, with a unique market segmentation for each application
- Material mix analysis underlining new opportunities for silicon
- Detailed supply chain and value chain analysis, providing evidence for material value and structure across the entire value chain SHOW LESS READ MORE >
1. Executive summary
- Report objectives
- Companies cited in this report
- What’s new since 2011?
3. What’s Happened Since 2011
- 2011 microfluidic device market
- EMMA 2011 forecast vs. real market data
- 2012 microfluidic device market
- Market data versus EMMA 2011 forecasts
- Microfluidic device market – major changes
- New collaborations
4. Microfluidic Markets: 2011-2018
- Microfluidic markets introduction
- 2012 microfluidic players
- Microfluidic device market
- Market data: Our market vision
- Pure fab players: top
- Microfluidic chips market
- Microfluidic tests market
5. Microfluidic applications
6. Materials mix analysis
- Material mix for point-of-care testing
- Material mix for pharmaceutical and life science
- Silicon for pharmaceutical research chips
7. Microfluidic product description
- Information provided for each product class
- Flow control components and modules
- Microfluidic dispensing devices for drug delivery
- Microfluidic devices for accurate dispensing
- Microfluidics for analytical devices
- Cartridges for clinical and veterinary diagnostics
- Microfluidic devices for point-of-care
- Microfluidics for industrial and environmental testing
- Microfluidics for pharmaceutical and life science research
- Microfluidic devices for micro reactions
8. Emerging application
9. Microfluidic technologies
10. Microfluidics value chain
11. Microfluidics supply chain
12. Summary and conclusions
- AB SCIEX
- Advion Biosciences
- AES Laboratoire
- Agilent Technologies
- Bartels Mikrotechnik
- Bertin Technologies
- Boehringer Ingelheim
- Caliper Life Sciences
- Eksigent Technologies
- GE Novasensor
- GenePOC Genewave
- Great Basin
- Johnson & Johnson
- Konica Minolta Opto
- Life Technologies
- MERLIN Diagnostika
- Pall Genesystem
- PositiveID Corporation
- Raindance Technologies
- Roche Applied Science
- Shrink Nanotechnologies
- Siemens Medical Solutions
- Sony DADC
- SpinChip Diagnostics
- Texas Instruments
- Tokyo Electron
- Vantix Ltd.